SODIUM CHLORIDE FRESENIUS KABI 0,9%

9MG/ML INF SOL 50X100ML I

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 17.12.2021
Interruption of marketing 08.12.2021 0176754, 0187183, 0187184, 0187192, 0187195, 0199942, 0218922, 0218923, 0218924, 0218925, 0234018, 0234021, 0234023, 0234024, 0234033, 0234039, 0234050, 0235772, 0051366, 0051367, 0051383, 0051384
Capacity/distribution reasons 15.12.2021
Resumption of marketing 22.10.2021
Interruption of marketing 01.10.2021 0176754, 0187183, 0187184, 0187192, 0187195, 0199942, 0218922, 0218923, 0218924, 0218925, 0234018, 0234021, 0234023, 0234024, 0234033, 0234039, 0234050, 0235772, 0051366, 0051367, 0051383, 0051384
Capacity/distribution reasons 18.10.2021
Resumption of marketing 06.05.2021
Interruption of marketing 20.04.2021 0176754, 0187183, 0187184, 0187192, 0187195, 0234018, 0234021, 0234023, 0234024, 0234033, 0234039, 0234050, 0235772, 0051366, 0051367, 0051383, 0051384
Capacity/distribution reasons 17.05.2021
Placing on the market 08.04.2019

All reports are available in the Overview.

Back to list